Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 15, 2012

View Archived Issues

Astellas Pharma highlights progress of third quarter of fiscal 2011

Maruho acquires U.S. company

Amarin gives update on FDA's review of AMR-101 NDA

Synthetic mast cell microparticles serve as vaccine adjuvants

Superhydrophobic materials allowing slow drug release designed in U.S.

New phase III data support once-weekly exenatide use for diabetes type 2

New prostanoid DP2 receptor antagonists prepared at Ironwood Pharmaceuticals

New metabotropic glutamate mGlu4 receptor modulators identified

Bayer Schering Pharma divulges novel protein kinase inhibitors

Nippon Chemiphar patents new candidate therapies for urinary incontinence

Novartis announces new prostanoid IP1 receptor agonists

Addex Pharmaceuticals designs new modulators of metabotropic glutamate mGlu4 receptor

RedHill Biopharma clear to conduct advanced-stage RHB-102 trial

Tiltan Pharma begins phase II study of TL-118

Soligenix announces promising results on SGX-201

Burnet Institute to receive grant for tuberculosis biomarkers

Compendia Bioscience enters partnership for next-generation cancer therapeutics

PROLOR Biotech reports additional preclinical data on long-acting clotting factor

Biogen Idec to acquire biotechnology company

Ziopharm reports encouraging overall survival data from study in soft tissue sarcoma

Columbia Laboratories transfers progesterone vaginal gel NDA

Phosphagenics reports results from trial of improved oxycodone patch

Phase II letermovir trial meets primary efficacy endpoints

Study provides proof of concept for TransVax cytomegalovirus vaccine

Newron and Meiji Seika Pharma finalize licensing agreement

SuppreMol reports interim phase Ib/IIa SM-101 data

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Probing bidirectional cancer-autoimmune link can yield new targets
BioWorld Science
Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.